Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Edward Schloss

Clinical Cardiac Electrophysiology Cincinnati, OH Medical Doctor

NPI 1972567964 CMS profile 817897

2123 Auburn Ave, Ste 137, Cincinnati, OH 45219

Open in the dashboard

General payments

$33,641

133 records reported · program years 2019–2025

Research payments

$6,950

Paid to them · 13 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$56,067 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Edward Schloss of Cincinnati, OH is reported in the CMS Open Payments database as having received $33,641 across 133 general payments and $6,950 in research payments paid to them. Separately, studies naming them as principal investigator received $56,067 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 70th percentile of Clinical Cardiac Electrophysiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

11 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $3,197 33
2025 Research $2,275 5
2024 General $312 8
2024 Research $2,450 5
2023 General $1,081 14
2023 Research $1,750 2
2022 General $5,077 22
2021 General $12,228 24
2021 Research $475 1
2020 General $5,081 10
2019 General $6,665 22

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Edward Schloss
  • Clinical Cardiac Electrophysiology median
  • Middle half of Clinical Cardiac Electrophysiology
  • National median

In program year 2025, general payments to Edward Schloss were reported at $3,197. Among 3,064 Clinical Cardiac Electrophysiology profiles paid that year, the median was $2,462 and the middle half received between $733 and $7,710.

Show as a table
Year Edward Schloss Clinical Cardiac Electrophysiology median Middle half National median
2019 $6,665 $2,361 $585–$8,260 $163
2020 $5,081 $993 $247–$4,351 $114
2021 $12,228 $1,185 $326–$4,739 $132
2022 $5,077 $2,073 $554–$6,789 $149
2023 $1,081 $2,568 $759–$8,159 $160
2024 $312 $2,557 $703–$7,403 $164
2025 $3,197 $2,462 $733–$7,710 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Medtronic, Inc. $15,882 70 payments
  2. Medtronic Vascular, Inc. $9,306 22 payments
  3. Boston Scientific Corporation $7,641 22 payments
  4. AOP Health US, LLC $306 1 payment
  5. Atricure, Inc. $216 5 payments
  6. Cardiva Medical, Inc. $83 3 payments
  7. Abbott Laboratories $83 4 payments
  8. Bardy Diagnostics, Inc. $50 2 payments
  9. Aziyo Biologics, Inc. $26 2 payments
  10. Biosense Webster, Inc. $25 1 payment
  11. Other $24 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $17,025 12 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $7,200 3 payments
  3. Travel and Lodging $5,110 26 payments
  4. Food and Beverage $4,306 92 payments
Products named General payments · program years 2019–2025
  1. GENERAL THERAPIES $3,300 2 payments
  2. General - Therapies Therapies $2,147 2 payments
  3. General - Therapies General - Therapies_Non Divisional $1,182 5 payments
  4. EVERA MRI XT DR SURESCAN $850 8 payments
  5. Micra $739 13 payments
  6. Adapta $739 1 payment
  7. Arctic Front $402 3 payments
  8. COBALT DR MRI SURESCAN $374 6 payments
  9. AURORA EV-ICD MRI SURESCAN $340 5 payments
  10. Rapiblyk $306 1 payment
  11. Other $2,256 47 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Medtronic, Inc. $6,950 13 payments

Prescribing to Medicare patients

Part D · data year 2024 · 15 drugs

Part D claims

1,023

Median for Clinical Cardiac Electrophysiology: 1,090

Drug cost

$393,353

Median for Clinical Cardiac Electrophysiology: $354,841

Branded share of claims

45.7%

Median for Clinical Cardiac Electrophysiology: 38.3%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Eliquis Apixaban Brand 308 $293,829
Xarelto Rivaroxaban Brand 76 $85,310
Dofetilide Generic 11 $5,183
Amiodarone Hcl Generic 89 $2,415
Metoprolol Succinate Generic 227 $1,970
Sotalol Sotalol Hcl Brand 63 $1,122
Flecainide Acetate Generic 32 $1,080
Diltiazem 24hr Er (Cd) Diltiazem Hcl Brand 20 $809
Digoxin Generic 20 $494
Bisoprolol Fumarate Generic 25 $335

The 10 drugs with the highest cost, of 15 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 2,573 Part D prescribers listed as Clinical Cardiac Electrophysiology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 62 billing codes

Paid by Medicare

$311,316

Medicare's payments for the services billed

Medicare patients

900

Average age 79

Services billed

8,122

351 women, 549 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Heart failure 65%
Ischemic heart disease 64%
Atrial fibrillation 61%
Arthritis 49%
Chronic kidney disease 44%
Diabetes 39%
Depression 24%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

1 product · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
JARDIANCE
  • Boehringer Ingelheim Pharmaceuticals, Inc. $24
$24 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

146 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Clinical Cardiac Electrophysiology in Ohio

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record